Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOHN J OPPENHEIMER

Allopathic & Osteopathic Physicians Allergy & Immunology Allergy

NPI
1639170871
CMS profile
209662
Location
CEDAR KNOLLS, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$178,177.21

141 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOHN J OPPENHEIMER

NPI 1639170871 · CMS profile ID 209662

Allopathic & Osteopathic Physicians / Allergy & Immunology / Allergy

CEDAR KNOLLS, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1639170871?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOHN J OPPENHEIMER, NPI 1639170871, CMS profile ID 209662. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1639170871?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). JOHN J OPPENHEIMER, NPI 1639170871, CMS profile ID 209662. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1639170871?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
JOHN J OPPENHEIMER, NPI 1639170871, CMS profile ID 209662, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1639170871?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

141 matching records · $178,177.21 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 141 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 141.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Ionis Pharmaceuticals, Inc. $21.0709/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246788692 CMS
GlaxoSmithKline, LLC. $7.5409/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190393609 CMS
Regeneron Healthcare Solutions, Inc. $19.7909/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213003780 CMS
GlaxoSmithKline, LLC. $13.1309/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190724224 CMS
GENZYME CORPORATION $16.1709/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233225452 CMS
Galderma Laboratories, L.P. $18.4809/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234686540 CMS
AstraZeneca UK Limited $5,250.0008/21/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1202967644 CMS
AstraZeneca UK Limited $3,850.0008/21/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1202975232 CMS
Novartis Pharmaceuticals Corporation $19.7608/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200758113 CMS
Galderma Laboratories, L.P. $9.4208/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234686538 CMS
GENZYME CORPORATION $103.9208/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233225448 CMS
GENZYME CORPORATION $11.0808/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233225450 CMS
GlaxoSmithKline, LLC. $19.9408/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191332964 CMS
GlaxoSmithKline, LLC. $4.0208/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190463768 CMS
CSL Behring $20.4208/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232377864 CMS
GlaxoSmithKline, LLC. $525.0008/06/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1190613506 CMS
BioCryst US Sales Co., LLC $16.9708/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222013613 CMS
AstraZeneca UK Limited $25,100.0007/31/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1202985904 CMS
AstraZeneca Pharmaceuticals LP $13.1807/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207100307 CMS
GlaxoSmithKline, LLC. $6,500.0007/29/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1190885582 CMS
GlaxoSmithKline, LLC. $2,600.0007/24/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1190339009 CMS
GlaxoSmithKline, LLC. $15.6107/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190711765 CMS
GlaxoSmithKline, LLC. $6,500.0007/21/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1190376687 CMS
GlaxoSmithKline, LLC. $10.2307/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190750420 CMS
ARS Pharmaceuticals Operations, Inc. $18.3207/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245886971 CMS
GlaxoSmithKline, LLC. $155.1107/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1190810227 CMS
GlaxoSmithKline, LLC. $162.7607/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1191209112 CMS
GlaxoSmithKline, LLC. $145.5207/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1191328084 CMS
GlaxoSmithKline, LLC. $19.5506/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190476140 CMS
GlaxoSmithKline, LLC. $3,250.0006/18/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1190360565 CMS
GlaxoSmithKline, LLC. $14.0706/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190387508 CMS
GlaxoSmithKline, LLC. $4,875.0006/16/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1190464135 CMS
GlaxoSmithKline, LLC. $173.8206/16/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1190803956 CMS
GlaxoSmithKline, LLC. $15.9706/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191400297 CMS
ARS Pharmaceuticals Operations, Inc. $15.3906/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245886969 CMS
GlaxoSmithKline, LLC. $10.5206/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190486746 CMS
GlaxoSmithKline, LLC. $49.3406/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190976094 CMS
GlaxoSmithKline, LLC. $49.3406/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191141407 CMS
GlaxoSmithKline, LLC. $18.4006/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191727967 CMS
GlaxoSmithKline, LLC. $14.3006/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191593214 CMS
GlaxoSmithKline, LLC. $18.4605/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191185023 CMS
AstraZeneca Pharmaceuticals LP $700.0005/22/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1206307601 CMS
GlaxoSmithKline, LLC. $8.5705/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191722388 CMS
Philips North America LLC $16.5005/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232621355 CMS
ABBVIE INC. $262.5005/13/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1203393025 CMS
GlaxoSmithKline, LLC. $10.6205/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190576253 CMS
Amgen Inc. $15.9005/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228523258 CMS
AstraZeneca UK Limited $13,100.0005/08/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1202918714 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.6705/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223782167 CMS
GlaxoSmithKline, LLC. $9,100.0005/02/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1190710167 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $39,189.53 110
PY2020 $157,099.72 51
PY2021 $135,337.01 82
PY2022 $95,576.46 95
PY2023 $185,923.53 139
PY2024 $131,185.76 136
PY2025 $178,177.21 141

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,537.50 4
PY2024 Recipient $273.74 1
PY2022 Recipient $3,119.01 6
PY2020 Recipient $3,672.00 2
PY2019 Recipient $6,633.47 4
PY2019 Principal investigator $877.71 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient ABBVIE INC. $525.00 12/15/2025 Covered Recipient Physician A Phase 2 Multicenter, Randomized, Platform Study of Advanced Therapies for the Treatment of Adult Subjects with Active Psoriatic Arthritis No dispute reported 06/30/2026 1202400312
Recipient ABBVIE INC. $262.50 11/15/2025 Covered Recipient Physician A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) No dispute reported 06/30/2026 1202400309
Recipient GENZYME CORPORATION $250.00 10/21/2025 Covered Recipient Physician A Randomized, Double-blind, Head-to-head Comparison of Dupilumab Versus Omalizumab in Severe Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) and Comorbid Asthma Patients No dispute reported 06/30/2026 1226086773
Recipient GENZYME CORPORATION $500.00 10/21/2025 Covered Recipient Physician A Randomized, Double-blind, Head-to-head Comparison of Dupilumab Versus Omalizumab in Severe Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) and Comorbid Asthma Patients No dispute reported 06/30/2026 1226086777